Cargando…
The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation
BACKGROUND: Lung cancer is the most frequently diagnosed malignant tumor and the highest mortality worldwide, and can be divided into two differential histologic subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). However, there are significant differences in diagnosis an...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459535/ https://www.ncbi.nlm.nih.gov/pubmed/36093542 http://dx.doi.org/10.21037/tcr-22-245 |